119 related articles for article (PubMed ID: 3044573)
1. Endocrine differentiation of gastric adenocarcinoma. The prevalence as evaluated by immunoreactive chromogranin A and its biologic significance.
Ooi A; Mai M; Ogino T; Ueda H; Kitamura T; Takahashi Y; Kawahara E; Nakanishi I
Cancer; 1988 Sep; 62(6):1096-104. PubMed ID: 3044573
[TBL] [Abstract][Full Text] [Related]
2. Biological and clinicopathological significance of endocrine differentiation of gastric adenocarcinoma evaluated by double immunohistochemical labeling for chromogranin A and bromodeoxyuridine.
Hayashi H; Ooi A; Nakanishi I
Jpn J Clin Oncol; 1990 Dec; 20(4):339-48. PubMed ID: 1704442
[TBL] [Abstract][Full Text] [Related]
3. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance.
de Bruïne AP; Wiggers T; Beek C; Volovics A; von Meyenfeldt M; Arends JW; Bosman FT
Int J Cancer; 1993 Jul; 54(5):765-71. PubMed ID: 8100808
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of endocrine differentiation in early and advanced stomach carcinoma].
Melissari M; Giordano G; Saragoni L; Bordi C
Pathologica; 1997 Apr; 89(2):133-7. PubMed ID: 9411359
[TBL] [Abstract][Full Text] [Related]
5. Chromogranin-A expression in gastric and colon cancer tissues.
Park JG; Choe GY; Helman LJ; Gazdar AF; Yang HK; Kim JP; Park SH; Kim YI
Int J Cancer; 1992 May; 51(2):189-94. PubMed ID: 1349007
[TBL] [Abstract][Full Text] [Related]
6. The incidence of chromogranin A defined endocrine cells decreases with tumour progression in gastric adenocarcinoma.
Ikeda Y; Mori M; Haraguchi Y; Sasaki O; Sugimachi K
Surg Oncol; 1995; 4(5):255-60. PubMed ID: 8850027
[TBL] [Abstract][Full Text] [Related]
7. Gastric carcinoma cells with endocrine differentiation show no evidence of proliferation.
Ooi A; Hayashi H; Katsuda S; Nakanishi I
Hum Pathol; 1992 Jul; 23(7):736-41. PubMed ID: 1351863
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A in the pancreatic islet: cellular and subcellular distribution.
Ehrhart M; Grube D; Bader MF; Aunis D; Gratzl M
J Histochem Cytochem; 1986 Dec; 34(12):1673-82. PubMed ID: 2878021
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin A (CgA) in the gastro-entero-pancreatic (GEP) endocrine system. II. CgA in mammalian entero-endocrine cells.
Cetin Y; Müller-Köppel L; Aunis D; Bader MF; Grube D
Histochemistry; 1989; 92(4):265-75. PubMed ID: 2807986
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin A (CGA) in the gastro-entero-pancreatic (GEP) endocrine system. I. CGA in the mammalian endocrine pancreas.
Grube D; Aunis D; Bader F; Cetin Y; Jörns A; Yoshie S
Histochemistry; 1986; 85(6):441-52. PubMed ID: 2877960
[TBL] [Abstract][Full Text] [Related]
11. Gastric and intestinal phenotypic correlation between exocrine and endocrine components in human stomach tumors.
Takenaka Y; Tsukamoto T; Mizoshita T; Ogasawara N; Hirano N; Otsuka T; Ban H; Nakamura T; Yamamura Y; Kaminishi M; Tatematsu M
Histol Histopathol; 2007 Mar; 22(3):273-84. PubMed ID: 17163401
[TBL] [Abstract][Full Text] [Related]
12. Electron microscopic immunohistochemical investigation of chromogranin A in endocrine cells in human oxyntic gastric mucosa.
Tzaneva MA
Acta Histochem; 2001 Apr; 103(2):179-94. PubMed ID: 11368099
[TBL] [Abstract][Full Text] [Related]
13. [Detection of CgA mRNA in neuroendocrine cells in gastric carcinoma by in situ hybridization].
Wang L; Shi J; Yu J
Zhonghua Bing Li Xue Za Zhi; 1995 Oct; 24(5):303-5. PubMed ID: 8745479
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53.
Eren F; Celikel C; Güllüoğlu B
Pathol Oncol Res; 2004; 10(1):47-51. PubMed ID: 15029262
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of gastric- and intestinal-type endocrine cells in gastric and intestinal mixed intestinal metaplasia of the human stomach.
Otsuka T; Tsukamoto T; Mizoshita T; Inada K; Takenaka Y; Kato S; Yamamura Y; Miki K; Tatematsu M
Pathol Int; 2005 Apr; 55(4):170-9. PubMed ID: 15826243
[TBL] [Abstract][Full Text] [Related]
17. Malignant potential regarding mucin phenotypes and endocrine cell differentiation in gastric adenocarcinoma.
Naritomi K; Futami K; Arima S; Iwashita A
Anticancer Res; 2003; 23(6a):4411-22. PubMed ID: 14666728
[TBL] [Abstract][Full Text] [Related]
18. Mixed gastric carcinoma with intestinal and cribriform patterns: a distinctive pathologic appearance associated with poor prognosis in advanced stages and a potential mimicker of metastatic breast carcinoma.
Lino-Silva LS; Salcedo Hernández RA; Molina-Frías E
Int J Surg Pathol; 2013 Feb; 21(1):6-14. PubMed ID: 22744963
[TBL] [Abstract][Full Text] [Related]
19. Chromogranin A expression in human colonic adenocarcinoma.
Romeo R; Pellitteri R; Mazzone V; Marcello MF
Ital J Anat Embryol; 2002; 107(3):177-83. PubMed ID: 12437144
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological study of chromogranin A, B and BRCA1 expression in node-negative breast carcinoma.
Yoshida R; Ohuchi N; Kimura N
Oncol Rep; 2002; 9(6):1363-7. PubMed ID: 12375049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
